Back

Adaptation of the Charlson Comorbidity Index for risk prediction and implantable defibrillator decision making in the older adult

13 April 2026 (08:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Poster session (2): device therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Jamie Bernard Mortiboys

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield (United Kingdom of Great Britain & Northern Ireland)

210 More presentations in this session

Presentation thumbnail
Genetic variants and device upgrade in young pacemaker recipients
Doctor J. Sanchez Moreno (Almeria, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy
Doctor A. Sahin (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Experiences with implantable loop recorders in syncope patients
Mr A. Oinonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Forcecardiography as a non-invasive predictor of echocardiographic parameters in patients undergoing cardiac resynchronization therapy: a preliminary study
Doctor V. Pergola (Naples, IT)
Abstract
Presentation thumbnail
Diagnostic work-up and clinical characteristics in out-of-hospital cardiac arrest survivors with ICD implantation: a prospective Danish study
Mr C. Hansen (Copenhagen, DK) Doctor B. Winkel (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session (2): device therapy

The Event

Event poster

EHRA 2026

13 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapies in primary prevention are not decreased in a contemporary cohort: insights from long-term follow-up
thumbnail
Congress Presentation
Predictors for adverse outcomes in ICD/CRT-D patients: insights from a single-center study
thumbnail
Congress Presentation
Clinical impact of ICD implantation in octogenarians: a longitudinal cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources